Somewhat surprisingly, given that CML cell lines responded to Src inhibition in vitro (67–71), Lyn, Hck, and Fgr were not required to induce CML in vivo (47). The gene discussed is HCK; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.